Development of AIDS in a Chimpanzee Infected with Human Immunodeficiency Virus Type 1

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 1997 May 1

PMID 9094687

Citations 57

Authors

F J Novembre

M Saucier

D C Anderson

S A Klumpp

S P ONeil

C R Brown 2nd

C E Hart

P C Guenthner

R B Swenson

H M McClure

Affiliations

Soon will be listed here.

Abstract

The condition of a chimpanzee (C499) infected with three different isolates of human immunodeficiency virus type 1 (HIV-1) for over 10 years progressed to AIDS. Disease development in this animal was characterized by (i) a decline in CD4+ cells over the last 3 years; (ii) an increase in viral loads in plasma; (iii) the presence of a virus, termed HIV-1JC, which is cytopathic for chimpanzee peripheral blood mononuclear cells; and (iv) the presence of an opportunistic infection and blood dyscrasias. Genetic analysis of the V1-V2 region of the envelope gene of HIV-1JC showed that the virus present in C499 was significantly divergent from all inoculating viruses (> or = 16% divergent at the amino acid level) and was suggestive of a large quasispecies. Blood from C499 transfused into an uninfected chimpanzee (C455) induced a rapid and sustained CD4+-cell decline in the latter animal, concomitant with high plasma viral loads. These results show that HIV-1 can induce AIDS in chimpanzees and suggest that long-term passage of HIV-1 in chimpanzees can result in the development of a more pathogenic virus.

Citing Articles

Stronger binding affinities of in provide insights into HIV/host interactions.

Li V, Lee C, Park T, Jarvis E, Kim H Infect Dis Model. 2024; 10(1):287-301.

PMID: 39620069 PMC: 11607582. DOI: 10.1016/j.idm.2024.10.003.

Comparative physiological anthropogeny: exploring molecular underpinnings of distinctly human phenotypes.

Vaill M, Kawanishi K, Varki N, Gagneux P, Varki A Physiol Rev. 2023; 103(3):2171-2229.

PMID: 36603157 PMC: 10151058. DOI: 10.1152/physrev.00040.2021.

Advancing HIV Broadly Neutralizing Antibodies: From Discovery to the Clinic.

Spencer D, Shapiro M, Haigwood N, Hessell A Front Public Health. 2021; 9:690017.

PMID: 34123998 PMC: 8187619. DOI: 10.3389/fpubh.2021.690017.

The HLA A03 Supertype and Several Species Major Histocompatibility Complex Class I A Allotypes Share a Preference for Binding Positively Charged Residues in the F Pocket: Implications for Controlling Retroviral Infections.

de Groot N, Heijmans C, de Ru A, Otting N, Koning F, Van Veelen P J Virol. 2020; 94(9).

PMID: 32075930 PMC: 7163143. DOI: 10.1128/JVI.01960-19.

Brain organoids and insights on human evolution.

Muotri A F1000Res. 2019; 8.

PMID: 31275562 PMC: 6544132. DOI: 10.12688/f1000research.18495.1.

References

Alter H, Eichberg J, Masur H, Saxinger W, Gallo R, Macher A . Transmission of HTLV-III infection from human plasma to chimpanzees: an animal model for AIDS. Science. 1984; 226(4674):549-52. DOI: 10.1126/science.6093251. View

Girard M, Meignier B, Barre-Sinoussi F, Kieny M, Matthews T, Muchmore E . Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1. J Virol. 1995; 69(10):6239-48. PMC: 189521. DOI: 10.1128/JVI.69.10.6239-6248.1995. View

Fultz P, McClure H, Swenson R, McGrath C, Brodie A, Getchell J . Persistent infection of chimpanzees with human T-lymphotropic virus type III/lymphadenopathy-associated virus: a potential model for acquired immunodeficiency syndrome. J Virol. 1986; 58(1):116-24. PMC: 252883. DOI: 10.1128/JVI.58.1.116-124.1986. View

Fultz P, Srinivasan A, Greene C, Butler D, Swenson R, McClure H . Superinfection of a chimpanzee with a second strain of human immunodeficiency virus. J Virol. 1987; 61(12):4026-9. PMC: 256026. DOI: 10.1128/JVI.61.12.4026-4029.1987. View

Lusso P, Markham P, Ranki A, Earl P, Moss B, Dorner F . Cell-mediated immune response toward viral envelope and core antigens in gibbon apes (Hylobates lar) chronically infected with human immunodeficiency virus-1. J Immunol. 1988; 141(7):2467-73. View

Fultz P, McClure H, Anderson D, Switzer W . Identification and biologic characterization of an acutely lethal variant of simian immunodeficiency virus from sooty mangabeys (SIV/SMM). AIDS Res Hum Retroviruses. 1989; 5(4):397-409. DOI: 10.1089/aid.1989.5.397. View

Zarling J, Ledbetter J, Sias J, Fultz P, EICHBERG J, Gjerset G . HIV-infected humans, but not chimpanzees, have circulating cytotoxic T lymphocytes that lyse uninfected CD4+ cells. J Immunol. 1990; 144(8):2992-8. View

BERMAN P, Gregory T, Riddle L, NAKAMURA G, Champe M, Porter J . Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160. Nature. 1990; 345(6276):622-5. DOI: 10.1038/345622a0. View

Fultz P, Siegel R, Brodie A, Mawle A, Stricker R, Swenson R . Prolonged CD4+ lymphocytopenia and thrombocytopenia in a chimpanzee persistently infected with human immunodeficiency virus type 1. J Infect Dis. 1991; 163(3):441-7. DOI: 10.1093/infdis/163.3.441. View

10.

Hirsch V, Zack P, Vogel A, Johnson P . Simian immunodeficiency virus infection of macaques: end-stage disease is characterized by widespread distribution of proviral DNA in tissues. J Infect Dis. 1991; 163(5):976-88. DOI: 10.1093/infdis/163.5.976. View

11.

Fultz P, Nara P, Barre-Sinoussi F, CHAPUT A, Greenberg M, Muchmore E . Vaccine protection of chimpanzees against challenge with HIV-1-infected peripheral blood mononuclear cells. Science. 1992; 256(5064):1687-90. DOI: 10.1126/science.256.5064.1687. View

12.

Agy M, Frumkin L, Corey L, Coombs R, Wolinsky S, Koehler J . Infection of Macaca nemestrina by human immunodeficiency virus type-1. Science. 1992; 257(5066):103-6. DOI: 10.1126/science.1621083. View

13.

Ghosh S, Fultz P, Keddie E, Saag M, Sharp P, Hahn B . A molecular clone of HIV-1 tropic and cytopathic for human and chimpanzee lymphocytes. Virology. 1993; 194(2):858-64. DOI: 10.1006/viro.1993.1331. View

14.

Johnson B, Stone G, Godec M, Asher D, Gajdusek D, Gibbs Jr C . Long-term observations of human immunodeficiency virus-infected chimpanzees. AIDS Res Hum Retroviruses. 1993; 9(4):375-8. DOI: 10.1089/aid.1993.9.375. View

15.

Schuitemaker H, Meyaard L, Kootstra N, Dubbes R, Otto S, Tersmette M . Lack of T cell dysfunction and programmed cell death in human immunodeficiency virus type 1-infected chimpanzees correlates with absence of monocytotropic variants. J Infect Dis. 1993; 168(5):1140-7. DOI: 10.1093/infdis/168.5.1140. View

16.

Estaquier J, Idziorek T, De Bels F, Barre-Sinoussi F, Hurtrel B, Aubertin A . Programmed cell death and AIDS: significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections. Proc Natl Acad Sci U S A. 1994; 91(20):9431-5. PMC: 44826. DOI: 10.1073/pnas.91.20.9431. View

17.

Dewar R, Highbarger H, Sarmiento M, Todd J, Vasudevachari M, Davey Jr R . Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasma. J Infect Dis. 1994; 170(5):1172-9. DOI: 10.1093/infdis/170.5.1172. View

18.

Pantaleo G, Menzo S, Vaccarezza M, Graziosi C, Cohen O, Demarest J . Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N Engl J Med. 1995; 332(4):209-16. DOI: 10.1056/NEJM199501263320402. View

19.

Hirsch V, DApolito G, Johnson P, Elkins W, London W, Montali R . Induction of AIDS by simian immunodeficiency virus from an African green monkey: species-specific variation in pathogenicity correlates with the extent of in vivo replication. J Virol. 1995; 69(2):955-67. PMC: 188664. DOI: 10.1128/JVI.69.2.955-967.1995. View

20.

Shibata R, HOGGAN M, Broscius C, Englund G, THEODORE T, Buckler-White A . Isolation and characterization of a syncytium-inducing, macrophage/T-cell line-tropic human immunodeficiency virus type 1 isolate that readily infects chimpanzee cells in vitro and in vivo. J Virol. 1995; 69(7):4453-62. PMC: 189187. DOI: 10.1128/JVI.69.7.4453-4462.1995. View